Репозиторий Dspace

Medical Device Development Process, and Associated Risks and Legislative Aspects-Systematic Review

Показать сокращенную информацию

dc.rights.license CC BY eng
dc.contributor.author Marešová, Petra cze
dc.contributor.author Klímová, Blanka cze
dc.contributor.author Honegr, Jan cze
dc.contributor.author Kuča, Kamil cze
dc.contributor.author Ibrahim, Wan Nur Hidayah cze
dc.contributor.author Selamat, Ali cze
dc.date.accessioned 2025-12-05T09:09:20Z
dc.date.available 2025-12-05T09:09:20Z
dc.date.issued 2020 eng
dc.identifier.issn 2296-2565 eng
dc.identifier.uri http://hdl.handle.net/20.500.12603/1057
dc.description.abstract Objective:Medical device development, from the product's conception to release to market, is very complex and relies significantly on the application of exact processes. This paper aims to provide an analysis and summary of current research in the field of medical device development methodologies, discuss its phases, and evaluate the associated legislative and risk aspects. Methods:The literature search was conducted to detect peer-reviewed studies in Scopus, Web of Science, and Science Direct, on content published between 2007 and November 2019. Based on exclusion and inclusion criteria, 13 papers were included in the first session and 11 were included in the second session. Thus, a total of 24 papers were analyzed. Most of the publications originated in the United States (7 out of 24). Results:The medical device development process comprises one to seven stages. Six studies also contain a model of the medical device development process for all stages or for just some of the stages. These studies specifically describe the concept stage during which all uncertainties, such as the clinical need definition, customer requirements/needs, finances, reimbursement strategy, team selection, and legal aspects, must be considered. Conclusion:The crucial factor in healthcare safety is the stability of factors over a long production time. Good manufacturing practices cannot be tested on individual batches of products; they must be inherently built into the manufacturing process. The key issues that must be addressed in the future are the consistency in the classification of devices throughout the EU and globally, and the transparency of approval processes. eng
dc.format p. "Article Number: 308" eng
dc.language.iso eng eng
dc.publisher FRONTIERS MEDIA SA eng
dc.relation.ispartof FRONTIERS IN PUBLIC HEALTH, volume 8, issue: 30. JUL eng
dc.subject medical devices eng
dc.subject development eng
dc.subject stages eng
dc.subject risks eng
dc.subject legislations eng
dc.title Medical Device Development Process, and Associated Risks and Legislative Aspects-Systematic Review eng
dc.type article eng
dc.identifier.obd 43876619 eng
dc.identifier.wos 000561559900001 eng
dc.identifier.doi 10.3389/fpubh.2020.00308 eng
dc.publicationstatus postprint eng
dc.peerreviewed yes eng
dc.source.url https://www.frontiersin.org/articles/10.3389/fpubh.2020.00308/full cze
dc.relation.publisherversion https://www.frontiersin.org/articles/10.3389/fpubh.2020.00308/full eng
dc.rights.access Open Access eng


Файлы в этом документе

Данный элемент включен в следующие коллекции

Показать сокращенную информацию

Поиск в DSpace


Просмотр

Моя учетная запись